Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
India accounts for 60% of the world's vaccines and
The Nobel Prize in Physiology or Medicine awarded
In today’s rapidly evolving bioprocessing landsc
Alembic Pharmaceutica
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Mi
India accounts for 60% of the world’s vaccines and 50% of generic medicines. Yet, as the industry is rapidly growing towards a market valuation of $130 billion in 2025, Indian pharmaceutical companies are bracing themselves for unprecedented regulatory scrutiny. The USFDA, MHRA, and EDQM inspections have become increasingly unyielding, while recent production stops due to contaminations at companies such as Granules India Ltd and Captab (Baddi) point to one important fact: microbial contamination is no longer just a compliance matter rather it is expected to be the fastest-growing pharmaceutical issue between 2025 and 2035. This is believed to make manufacturing companies in India invest in stricter sanitation and validated disinfectant systems.
Industry conferences, like Pharma India 2025, illustrate validation of disinfectants as a key area of focus. The CDSCO continues to move toward international standards, while supplier audit requirements for ready-to-sterilize components have become increasingly more stringent. The message is clear – continuous validation is the new normal.
Bioguard’s portfolio of validated disinfectants is the perfect choice, which addresses broad-spectrum contamination control needs while bringing forth measurable business value.
The solutions by Bioguard are validated according to USP Chapter <1072> and independently tested against multiple European standards such as EN13624, EN13727, EN14476, EN17126, EN14348, and EN16615, which makes them suitable for EDQM-accredited plants.
All the products go through lab testing in real-world dirty conditions which gives confidence in real manufacturing situations
Part of what sets Bioguard apart is the combination of efficacy with operational practicality:
Compatible with stainless steel, epoxy, glass, aluminium, PVC, HDPE, and acrylic surfaces to protect your equipment investment while ensuring comprehensive facility coverage.
Bioguard Concentrate: Used in high bioburden zones and Grade C/D areas during Shutdowns & weekly deep cleaning for Pre-sterilization routines:
This creates a low microbial baseline, allowing the cleaning operation to be more effective.
Bioguard Ready-to-Use (RTU): Batch change-over, filling line surface, RABS, Isolators, pass boxes, Machine touch points, and sampling & dispensing points represent some of the facilities where quick cleaning and disinfection are required.
Bioguard Hand Foam (Validated Hand Hygiene): Bioguard’s alcohol-free foam helps break the chain of cleanroom contamination that happens mostly due to operators’ hand hygiene.
Bioguard’s 3-step system — Deep Disinfection with Concentrate, On-the-Go protection with RTU, and hand hygiene for Hand Foam Sanitiser — represents a new standard: validated to international benchmarks, tested in real-world conditions, operationally efficient, and supported with comprehensive documentation.
As global regulatory expectations intensify, contamination control is no longer optional. The choice of a disinfection partner directly impacts market access, audit readiness, and long-term competitiveness.
Bioguard’s validated solutions deliver the performance, economic efficiency, and regulatory confidence Indian manufacturers need to lead India’s Quality Revolution in pharmaceutical manufacturing.